These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19241619)

  • 81. FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Nierengarten MB
    Cancer; 2024 Jun; 130(11):1903. PubMed ID: 38757625
    [No Abstract]   [Full Text] [Related]  

  • 82. FDA approves PI3K inhibitor for a rare immune disorder.
    Mullard A
    Nat Rev Drug Discov; 2023 May; 22(5):342. PubMed ID: 37041237
    [No Abstract]   [Full Text] [Related]  

  • 83. FDA approves first MASH drug.
    Nat Biotechnol; 2024 Apr; 42(4):540. PubMed ID: 38632447
    [No Abstract]   [Full Text] [Related]  

  • 84. FDA approves first-in-class AKT inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 Jan; 23(1):9. PubMed ID: 38049466
    [No Abstract]   [Full Text] [Related]  

  • 85. FDA approves cord-blood therapy.
    Nat Biotechnol; 2023 May; 41(5):589. PubMed ID: 37193840
    [No Abstract]   [Full Text] [Related]  

  • 86. FDA approves new combined treatment for advanced prostate cancer.
    Cancer; 2023 Dec; 129(24):3841-3842. PubMed ID: 38102101
    [No Abstract]   [Full Text] [Related]  

  • 87. FDA approves fifth RNAi drug - Alnylam's next-gen hATTR treatment.
    Mullard A
    Nat Rev Drug Discov; 2022 Aug; 21(8):548-549. PubMed ID: 35794463
    [No Abstract]   [Full Text] [Related]  

  • 88. FDA approves new antibiotic combination for drug-resistant pneumonia.
    Mullard A
    Nat Rev Drug Discov; 2023 Jul; 22(7):527. PubMed ID: 37286780
    [No Abstract]   [Full Text] [Related]  

  • 89. In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability.
    Staud R
    Ann Intern Med; 2022 Oct; 175(10):JC118. PubMed ID: 36191311
    [TBL] [Abstract][Full Text] [Related]  

  • 90. FDA approves second RNA aptamer.
    Mullard A
    Nat Rev Drug Discov; 2023 Oct; 22(10):774. PubMed ID: 37673979
    [No Abstract]   [Full Text] [Related]  

  • 91. FDA approves first anti-IL-36 receptor antibody for rare skin disease.
    Mullard A
    Nat Rev Drug Discov; 2022 Nov; 21(11):786. PubMed ID: 36216878
    [No Abstract]   [Full Text] [Related]  

  • 92. Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns.
    Mahase E
    BMJ; 2023 Jan; 380():73. PubMed ID: 36631154
    [No Abstract]   [Full Text] [Related]  

  • 93. FDA approves first cell therapy for wrinkle-free visage.
    Schmidt C
    Nat Biotechnol; 2011 Aug; 29(8):674-5. PubMed ID: 21822225
    [No Abstract]   [Full Text] [Related]  

  • 94. US approves first nasal spray for anaphylaxis.
    Mahase E
    BMJ; 2024 Aug; 386():q1789. PubMed ID: 39134319
    [No Abstract]   [Full Text] [Related]  

  • 95. FDA approves new sterilants.
    Infect Control Hosp Epidemiol; 1998 Mar; 19(3):217. PubMed ID: 9552192
    [No Abstract]   [Full Text] [Related]  

  • 96. FDA approves new agent for the treatment of metastatic prostate cancer.
    BJU Int; 2022 Jul; 130(1):3-4. PubMed ID: 35768143
    [No Abstract]   [Full Text] [Related]  

  • 97. What is the progress of experimental drug development for fibromyalgia?
    Lawson K
    Expert Opin Investig Drugs; 2023; 32(7):563-565. PubMed ID: 37357750
    [No Abstract]   [Full Text] [Related]  

  • 98. FDA approves RNA-targeting small molecule.
    Mullard A
    Nat Rev Drug Discov; 2020 Oct; 19(10):659. PubMed ID: 32884109
    [No Abstract]   [Full Text] [Related]  

  • 99. FDA approves first schizophrenia drug with new mechanism of action since 1950s.
    Kingwell K
    Nat Rev Drug Discov; 2024 Nov; 23(11):803. PubMed ID: 39333712
    [No Abstract]   [Full Text] [Related]  

  • 100. Molecule of the month. FDA approves new treatment for fibromyalgia.
    Lindsley CW
    Curr Top Med Chem; 2009; 9(2):225. PubMed ID: 19241619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.